Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression

BACKGROUND: Sodium-glucose cotransporter-2 (SGLT2) inhibitors (SGLT2i) showed benefits in type 1 diabetes mellitus (T1DM), but the risk of diabetic ketoacidosis (DKA) limits their use. Ability to predict DKA risk and therapeutic responses would enable appropriate patient selection for SGLT2i. We con...

Descripción completa

Detalles Bibliográficos
Autores principales: Musso, Giovanni, Sircana, Antonio, Saba, Francesca, Cassader, Maurizio, Gambino, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771708/
https://www.ncbi.nlm.nih.gov/pubmed/33373368
http://dx.doi.org/10.1371/journal.pmed.1003461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771708/
https://www.ncbi.nlm.nih.gov/pubmed/33373368
http://dx.doi.org/10.1371/journal.pmed.1003461

Ejemplares similares